The copyrights of this document belong to the International Headache Society Committee on Clinical Trials in Migraine. This document is not copyrighted in the English version provided the source is acknowledged. Translations to other languages must be authorized by a national headache society associated with the International Headache Society.
Get full access to this article
View all access options for this article.
References
1.
SchwartzDLellouchJExplanatory and pragmatic attitudes in therapeutic trials.J Chronic Dis1967;20:637–48
2.
GoodCSThe principles and practice of clinical trials.Edinburgh, London, New York:Churchill Livingstone1976
3.
PocockSJClinical Trials. A practical approach.Chichester, New York, Brisbane, Toronto, Singapore:John Wiley & Sons1983
4.
SpilkerBGuide to clinical studies and developing protocols.New York:Raven Press1984
5.
MeinertCLClinical trials-design, conduct, and analysis.New York:Oxford University Press1986
6.
OlesenJKrabbeAÆTfelt-HansenPMethodological aspects of prophylactic drug trials in migraine.Cephalalgia1981;1:127–41
7.
Tfelt-HansenPOlesenJMethodological aspects of drug trials in migraine.Neuroepidemiology1985;4:204–26
8.
GerberW-DSoykaDNiederbergerUHaagGProbleme unc Ansätze zur Anlage und Bewertung von Therapiestudien bei Kopfschmerzpatienten.Der Schmerz1987;1:81–91
9.
CliffordRose F, edMethodological problems in migraine trials.Neuroepidemiology1987;6:163–238
10.
OlesenJTfelt-HansenPMethodology of migraine trials. In:OrgogozoJ-M,Capildeo Reds Methods in clinical trials in neurology. Vascular and degenerative brain disease.London:Macmillan Press Ltd1988;85–109
HockadayJMProblems in childhood migraine.Neuroepidemiology1987;6:234–8
13.
Toko1aRAKangasniemiPNeuvonenPJTokolaOTolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks.Cephalalgia1984;4:253–63
14.
JohnsonESRadcliffDMWilkinsonMNaproxen sodium in the treatment of migraine.Cephalalgia1985;5:5–10
15.
LarsenBHChristiansenLVAndersenBOlesenJRandomized double-blind comparison of tolfenamic acid and paracetamol in migraine.Acta Neurol Scand1990;81:464–7
16.
GardnerMJAltmanDGConfidence intervals rather than P values: estimation rather than hypothesis testing.Br Med J1986;292:746–50
17.
Tfelt-HansenPEfficacy of beta-blockers in migraine. A critical review.Cephalalgia1986;6(suppl 5):15–24
18.
OlesenJThe role of calcium entry blockers in the prophylaxis of migraine.Eur Neurol1986;25(suppl 1):72–9
19.
Tfelt-HansenPJacobsenHLAndersenPKStatistical review of prophylactic trials in migraine. In preparation
20.
LewisJAMigraine trials: crossover or parallel group.Neuroepidemiology1987;6:198–208
21.
SorensenPHansenKOlesenJA placebo-controlled, double-blind, crossover trial of flunarizine in common migraine.Cephalalgia1986;6:7–14
22.
Tfelt-HansenPStandnesBKangasniemiPHakkarainenHOlesenJTimolol vs propranolol vs placebo in common migraine prophylaxis.Acta Neurol Scand1984;69:1–8
23.
LangohrHDGerberWDKoletzkiEMayerKSchrothGClomipramine and metoprolol in migraine prophylaxis-a double-blind crossover study.Headache1985;25:107–13
24.
Tfelt-HansenPNielsenSLPatient numbers needed in prophylactic migraine trials.Neuroepidemiology1987;6:214–19
